A recent study indicates that patients who come off popular slimming jabs like Wegovy and Mounjaro may regain shed pounds much more quickly than those who end conventional diet and exercise regimens.
Published data in a prominent medical journal demonstrates that while overweight people can lose about a fifth of their total mass while undergoing treatment, the mass is regained at an average rate of 0.8 kg per month after stopping.
"Users buying these medications must be cognizant of the potential of rapid weight regain when the therapy concludes," warns expert Dr. Susan Jebb.
Such speed of regain means a reversion to original weight within about 18 months.
Comparing Treatments
The analysis, which reviewed 37 of studies involving thousands of patients, contrasted the effects of GLP-1 agonists with other pills.
Researchers emphasize that people who lose weight through diet and exercise usually see a more gradual creep back—perhaps 0.1 kg a month—once they finish.
Explaining the Rapid Rebound
Nutrition scientists propose the way of the injections explains the amplified rebound.
These medications imitate a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing the hormone levels far above than normal might result in the body to produce less of its own natural hormone, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication means hunger is uncontrolled, making excessive eating a significant risk."
An Ongoing Condition?
The NHS recommend the injections for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians argue that, given the high risk of relapse, the treatment is often life-long.
This view is echoed by drug manufacturers, who say that the results "emphasize the persistent character of obesity," similar to managing conditions like high blood pressure.
User Accounts
People who have come off the medication explain a intense return of appetite.
"I experienced a switch activating and you become starving," recalled an individual.
This challenge is compounded if patients have not established sustainable lifestyle or habit modifications during therapy.
Growing Interest
Figures show that millions of people in the UK have used weight-loss jabs in the past year, with desire remaining high.
- Adoption is greater among females than males.
- The middle-aged demographic shows the highest level of interest.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, clinicians stress that while these medications are potent agents for shedding pounds, they are not a standalone cure and maintained weight loss likely depends on ongoing lifestyle management.
